Trial intelligence / Profile preview

MEDEX: Exercise and Venlafaxine for Depression

NCT02407704Phase 4Completed

Start
Mar 2015
Primary completion
Nov 2016
Countries
1
01

Overview

Phase 4, randomised trial (2 arms). Primary endpoint: Number of Participants Experiencing Remission at 12 weeks. Started Mar 2015; status: completed.

Beyond the preview

Go deeper on NCT02407704.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02407704.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call